Involvement of CPP32/Yama-like protease in CPT-11-induced death signal transduction pathway

Toxicology in Vitro

Volumn 10, Issue 6, 1996, Pages 693-700

  Suzuki, A ^b   Matsuzawa, A ^a   Kato, M ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CAMPTOTHECIN; CYCLOHEXIMIDE; FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; IRINOTECAN; PROTEIN SYNTHESIS INHIBITOR; PROTEINASE; TETRAPEPTIDE;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CELL VIABILITY; CYTOTOXICITY; DAUDI CELL; HUMAN; HUMAN CELL; PREVENTION; SIGNAL TRANSDUCTION;

EID: 0030512693     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(96)00061-6     Document Type: Article

References (23)

1. Enari M., Hug H. and Nagata S. (1995) Involvement of an ICE-like proteinase in Fas-mediated apoptosis. Nature 375, 78-81.
2. Glisson B. S. and Ross W. E. (1987) DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy. Pharmacology and Therapeutics 4338-4344.
3. Hasegawa J., Kamada S., Kamiike W., Shimizu S., Imazu T., Matsuda H. and Tsujimoto Y. (1996) Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. Cancer Research 56, 1713-1718.
4. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y. and Nagata S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
5. Kohn K. W., Pommier Y., Kerrigan D., Markovitts J. and Covey J. M. (1987) Topoisomerase II as a target of anticancer drug action in mammalian cells. National Cancer Institute Monograph 4, 61-71.
6. Kondo S., Yin D., Takeuchi J., Morimura T., Oda Y. and Kikuchi H. (1994) bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow) induced by chemotherapy. British Journal of Cancer 70, 421-426.
7. Lazebnic Y. A., Kaufmann S. H., Desnoyers S., Poirier G. G. and Earnshaw W. C. (1994) Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
8. Mashima T., Naito M., Kataoka S., Kawai H. and Tsuruo T. (1995) Aspartate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukaemia U937 cells. Biochemical and Biophysical Research Communications 209, 907-915.
9. Miura M., Zhu H., Rotello R., Hartweig E. A. and Yuan J. (1993) Induction of apoptosis in fibroblasts by IL-i beta converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-660.
10. Mossman T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. Journal of Immunological Methods 65, 55-63.
11. Nagata S. (1994) Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas. Philosophical Transactions of the Royal Society of London 345, 281-287.
12. Nagata S. and Golstein P. (1995) The Fas death factor. Science 267, 1449-1456.
13. Nicholson D. W., Ali A., Thornberry N. A., Valliancourt J. P., Ding C. K., Michel G., Gareau Y., Griffin P. R., Labelle M., Lazebnic Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T.-T., Yu V. L. and Miller D. K. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
14. Onishi Y., Azuma Y., Sato Y., Mizuno Y., Tadakuma T. and Kizaki H. (1993) Topoisomerase inhibitors induce apoptosis in thymocytes. Biochimica et Biophysica Acta 1175, 147-154.
15. Ray C. A., Black R. A., Kronheim S. R., Greenstreet T. A., Sleath P. R., Salvesen G. S. and Pickup D. J. (1992) Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69, 597-604.
16. Suda T., Takahashi T., Golstein P. and Nagata S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumour necrosis factor family. Cell 75, 1169-1178.
17. Suzuki A., Enari M., Eguchi Y., Matsuzawa A., Nagata S., Tsujimoto Y. and Iguchi T. (1996) Involvement of Fas in regression of vaginal epithelia after ovariectomy and during an estrous cycle. EMBO Journal 15, 211-215.
18. Thornberry N. A., Peterson E. P., Zhao J. J., Howard A. D., Griffin P. R. and Chapman K. T. (1994) Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy) methyl ketones. Biochemistry 33, 3934-3940.
19. Wagai N. and Tawara K. (1992) Possible direct role of reactive oxygens in the cause of cutaneous phytotoxicity induced by five quinolones in mice. Archives of Toxicology 66, 392-397.
20. Walker P. R., Smith C., Youdale T., Leblanc J., Whitfield J. F. and Sikorska M. (1991) Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Research 51, 1078-1085.
21. Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A. and Nagata S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
22. Yonehara S., Ishii A. and Yonehara M. (1989) A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumour necrosis factor. Journal of Experimental Medicine 169, 1747-1756.
23. Zweling L. A. (1989) Topoisomerase II as a target of antileukemia drugs: a review of controversial areas. Human Pathology 3, 101-112.